PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC | PubSys CalAccessCommittee header
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA IEC
Active cycles
2003-20042005-20062007-20082009-20102011-20122013-20142015-20162017-20182019-20202021-20222023-20242025-2026
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2007-2008 cycle
- Raised
- $1,017,992Dated receipts + reported unitemized intervals
- Spent
- $817,531
- Net activity
- $200,461
Receipt coverage evidence (42 components)
- Filing 1264357, amendment 0, F497P2: Receipt date 2007-04-30; $10,000.00; s497_not_received
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P2: Receipt date 2007-06-13; $35,000.00; s497_not_received
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $3,999.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $3,999.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $3,999.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $3,999.00; covered_by_regular_filing
- Filing 1273483, amendment 0, F497P1: Receipt date 2007-06-04; $44,000.00; covered_by_regular_filing
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 96.9% of dated attributable receipts.
Dominant category: Operations at 99.2% of spending.
Funding distribution
$5,000+
Count: 21
Share: 96.9%
Amount: $986,000
$1,000 - $4,999
Count: 8
Share: 3.1%
Amount: $31,992
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageLarge-donor funded, Non-media-led spender, Active in 2007-2008 cycle.
Money over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
ContributionsExpenditures
Jan 2007Sep 2007Apr 2008Dec 2008
| $5,000+ | 21 | $986,000 | 96.9% |
| $1,000 - $4,999 | 8 | $31,992 | 3.1% |
Spending categories
Operations
Amount: $810,982
Share: 99.2%
Consulting
Amount: $6,549
Share: 0.8%
| Category | Amount | Share of spent |
|---|
| Operations | $810,982 | 99.2% |
| Consulting | $6,549 | 0.8% |
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|
| ABBOTT LABORATORIES | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| AMGEN, INC. | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| ASTELLAS PHARMA US, INC. | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| BRISTOL MYERS SQUIBB COMPANY | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| ELI LILLY & COMPANY | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| GLAXOSMITHKLINE | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| JOHNSON & JOHNSON SERVICES INC. | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| MERCK & CO. | $98,000 | 9.6% | 2 | Sep 2, 2008 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $98,000 | 9.6% | 2 | Sep 2, 2008 |
| PFIZER INC. | $98,000 | 9.6% | 2 | Mar 25, 2008 |
| HOFFMANN - LA ROCHE | $7,998 | 0.8% | 2 | Mar 25, 2008 |
| SCHERING-PLOUGH CORPORATION | $6,000 | 0.6% | 1 | Jan 21, 2008 |
| MEDPOINTE | $3,999 | 0.4% | 1 | Apr 6, 2007 |
| PURDUE PHARMA, L.P. | $3,999 | 0.4% | 1 | Mar 25, 2008 |
| SEPRACOR, INC. | $3,999 | 0.4% | 1 | Mar 25, 2008 |
| SERONO | $3,999 | 0.4% | 1 | Sep 2, 2008 |
| SOLVAY PHARMACEUTICALS | $3,999 | 0.4% | 1 | Apr 6, 2007 |
| VALEANT | $3,999 | 0.4% | 1 | Apr 6, 2007 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.